Tandem Diabetes Care Inc
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | – | – | -41.1% | +351.4% | -54.7% | -163.0% | – | -140.1% | |
| – | +10.0% | +13.7% | +25.1% | -15.2% | +4.3% | +72.1% | +32.5% | +3.5% | +9.7% | +5.7% | -16.7% | |
| – | -12.7% | -11.0% | +8.3% | +88.0% | +144.7% | +0.6% | +4.0% | +39.8% | +3.7% | +15.1% | -8.9% | |
| – | -11.3% | +20.8% | -13.4% | +584.9% | -24.8% | +3.9% | -14.3% | +85.9% | – | – | – | |
| – | – | – | -14,483.0% | – | -246.0% | – | – | -132.3% | – | – | – | |
| – | +27.5% | +53.0% | -36.0% | -47.8% | +554.4% | +65.3% | -27.2% | +45.0% | -21.4% | -28.3% | +3.7% | |
| – | – | +331.6% | -73.4% | -3,361.6% | -37.2% | +419.8% | -36.9% | – | -358.5% | -72.6% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | -7.4% | -31.6% | -75.4% | +5,508.1% | -24.3% | +188.4% | -25.6% | -66.2% | – | – | – | |
| – | – | +0.0% | -116.0% | +996.4% | – | +0.0% | -100.0% | – | – | – | -167.1% | |
| – | +1,775.7% | -23.4% | -38.1% | +261.9% | -79.3% | +1,199.0% | -83.5% | -67.5% | -75.6% | +103.4% | -618.3% | |
| – | – | -86.7% | -2,048.3% | – | -48.4% | +364.6% | -153.9% | – | -212.2% | – | +106.4% | |
| – | – | – | – | – | – | -134.1% | – | -81.4% | -458.1% | – | -694.1% |
Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.